Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Deals
AcornMed Raises RMB 200 Million in Series B Financing Led by Yikai Venture Capital
January 27, 2025
Company
Drug
CSPC’s NBL-020 Receives FDA IND Approval for Advanced Solid Tumors
January 27, 2025
Company
Drug
Jiangsu Chia Tai Tianqing’s TQB2102m Gains NMPA Clinical Approval
January 27, 2025
Company
Deals
WuXi XDC Partners with GeneQuantum for ADC Development
January 27, 2025
Company
Drug
Hengrui Pharmaceuticals Receives New Approval for Remimazolam Tosylate
August 26, 2025
Company
Deals
Neurophth Partners with Apellis for Gene Therapy Development in AMD
January 27, 2025
Company
Drug
Jing Medicine’s HJM-353 Gains Clinical Trial Approvals in US and China
January 27, 2025
Company
Deals
Jiangsu Vcare PharmaTech Raises RMB 200 Million in Series B Financing Round
January 27, 2025
Company
Drug
MindRank AI Receives FDA Approval for MDR-001 Clinical Study in Obesity
January 27, 2025
Company
Medical Device
Hangzhou Biotest Receives FDA EUA for COVID-19 Antigen Self-Testing Reagent
January 27, 2025
Company
Deals
Junshi Biosciences Licenses PD-1 Inhibitor Tuoyi to Hikma MENA FZE
January 27, 2025
Company
Deals
Shanghai Pharmaceuticals Secures Exclusive Rights for Shionogi’s Ensitrelvir in China
January 27, 2025
1
2
…
1,064
1,065
1,066
1,067
1,068
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?